Granot Yoav, Meir Yuval, Perl Michal Laufer, Milwidsky Assi, Sadeh Ben, Sapir Orly Ran, Trabelsi Adva, Banai Shmuel, Toplisky Yan, Havakuk Ofer
Department of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, 6423906, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Clin Res Cardiol. 2025 May;114(5):609-615. doi: 10.1007/s00392-024-02473-8. Epub 2024 Jun 3.
Examine the performance of a simple echocardiographic "Killip score" (eKillip) in predicting heart failure (HF) hospitalizations and mortality after index event of decompensated HF hospitalization.
HF patients hospitalized at our facility between 03/2019-03/2021 who underwent an echocardiography during their index admission were included in this retrospective analysis. The cohort was divided into 4 classes of eKillip according to: stroke volume index (SVI) < 35ml/m > and E/E' ratio < 15 > . An eKillip Class I was defined as SVI ≥ 35ml/m and E/E' ≤ 15 and was used as reference.
Included 751 patients, median age 78.1 (IQR 69.3-86) years, 59% men, left ventricular ejection fraction 45 (IQR 30-60)%, brain natriuretic peptide levels 634 (IQR 331-1222)pg/ml. Compared with eKillip Class I, a graded increase in the combined endpoint of 30-day mortality and rehospitalizations rates was noted: (Class II: HR 1.77, CI 0.95-3.33, p = 0.07; Class III: HR 1.94, CI 1.05-3.6, p = 0.034; Class IV: HR 2.9, CI 1.64-5.13, p < 0.001 respectively), which overall persisted after correction for clinical (Class II: HR 1.682, CI 0.9-3.15, p = 0.105; Class III: HR 2.104, CI 1.13-3.9, p = 0.019; Class IV: HR 2.74, CI 1.54-4.85, p = 0.001 respectively) or echocardiographic parameters (Class II: HR 1.92, CI 1.02-3.63, p = 0.045; Class III: HR 1.54, CI 0.81-2.95, p = 0.189; Class IV: HR 2.04, CI 1.1-3.76, p = 0.023 respectively). Specifically, the eKillip Class IV group comprised one-third of the patient population and persistently showed increased risk of 30-day HF hospitalizations or mortality following multivariate analysis.
A simple echocardiographic score can assist identifying high-risk decompensated HF patients for recurrent hospitalizations and mortality.
研究一种简单的超声心动图“Killip评分”(eKillip)在预测失代偿性心力衰竭住院指数事件后心力衰竭(HF)住院率和死亡率方面的表现。
纳入2019年3月至2021年3月在我院住院且在首次入院期间接受超声心动图检查的HF患者进行这项回顾性分析。根据每搏输出量指数(SVI)<35ml/m²>和E/E'比值<15>将队列分为4类eKillip。将eKillip I类定义为SVI≥35ml/m²且E/E'≤15,并用作对照。
共纳入751例患者,中位年龄78.1(四分位间距69.3 - 86)岁,男性占59%,左心室射血分数45(四分位间距30 - 60)%,脑钠肽水平634(四分位间距331 - 1222)pg/ml。与eKillip I类相比,30天死亡率和再住院率的联合终点呈分级增加:(II类:HR 1.77,CI 0.95 - 3.33,p = 0.07;III类:HR 1.94,CI 1.05 - 3.6,p = 0.034;IV类:HR 2.9,CI 1.64 - 5.13,p < 0.001),在对临床参数(II类:HR 1.682,CI 0.9 - 3.15,p = 0.105;III类:HR 2.104,CI 1.13 - 3.9,p = 0.019;IV类:HR 2.74,CI 1.54 - 4.85,p = 0.001)或超声心动图参数进行校正后总体依然存在(II类:HR 1.92,CI 1.02 - 3.63,p = 0.045;III类:HR 1.54,CI 0.81 - 2.95,p = 0.189;IV类:HR 2.04,CI 1.1 - 3.76,p = 0.023)。具体而言,eKillip IV类组占患者总数的三分之一,多因素分析后持续显示30天HF住院或死亡风险增加。
一种简单的超声心动图评分有助于识别失代偿性HF高危患者的再住院和死亡风险。